 | PharmaPoint: HIV China Drug Forecast and Market Analysis to 2022Viral Infections◇ 医療 介護 福祉 RCP |
1:SymptomsHIV15Table2CompetitiveAssessmentofLate-StagePipelineAgentsinHIV,201282Table31ProductProfile?Cobicistat84Table32CobicistatSWOTAnalysis,201269Table27OverallUnmetNeeds?CurrentLevelofAttainment70Table26SummaryofMinorTherapeuticClassesinDevelopmentforHIV,201283Table31ProductProfile?Isentress66Table24PercentofPatientswithHIVRNALevelsTable25IsentressSWOTAnalysis,201269Table27OverallUnmetNeeds?CurrentLevelofAttainment70Table28ClinicalUnmetNeeds?GapAnalysis,201269Table27OverallUnmetNeeds?GapAnalysis,2012?2022116"本商品の記載内容は、お客様の問題解決のためのヒントとしてご利用ください。
| PharmaPoint: HIV China Drug Forecast and Market Analysis to 2022Viral Infections◇ 医療 介護 福祉 RCP |
次>